Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Apax Partners on the operation. Magaya Corporation announced that funds advised by Apax Digital, the growth equity arm of global private equity advisory...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton advised CD&R, Kirkland & Ellis advised Whitcraft and Greenbriar, Latham & Watkins advised Paradigm and Carlyle on the deal. Clayton, Dubilier & Rice...
You must be a Standard 1 Year member to access this content.
Simpson Thacher advised KKR, while Kirkland & Ellis and Houthoff advised Funds advised by Apax Partners on the deal. KKR announced its definitive agreement to acquire...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Bryan Cave acted as legal advisors to RapidRatings. Latham & Watkins acted as legal advisors to Spectrum Equity and Sidley Austin acted...
You must be a Standard 1 Year member to access this content.
